DAPT-CHF Subgroup Analysis Index Calculator
Index calculation
Enter patient characteristics to calculate the arithmetic index implemented in the original template.
This custom index has not been established as a validated decision rule. Do not use it alone to determine DAPT duration.
About this index
The supplied template combines age, diabetes, prior MI, stent diameter, bleeding history, heart failure status, and LVEF into a single arithmetic score. The combination and the resulting categories should be treated as a locally constructed heuristic rather than a validated clinical prediction model.
Weights implemented from the original file
| Variable | Rule in original code | Points |
|---|---|---|
| Age ≥75 years | Age 75 years or older | −2 |
| Age 65 to <75 years | Age at least 65 and below 75 | −1 |
| Diabetes mellitus | Present | +1 |
| Prior MI | Present | +1 |
| Stent diameter <3 mm | Present | +1 |
| History of bleeding | Present | −1 |
| Heart failure | Present | −1 |
| LVEF <40% | Present | −1 |
Interpretation limits
The original template assigned categories at scores ≥2, 0–1, and below 0. These are displayed only as legacy categories for transparency; no clinical benefit, bleeding probability, or treatment recommendation can be inferred from those cutoffs without external validation.
In particular, the validated DAPT Score uses a different set of variables and weights. A history of bleeding is not a component of the original DAPT Score, and the original score assigns +2 for congestive heart failure or LVEF <30%, rather than the separate negative weights used here. The custom index must not be presented as the validated DAPT Score.
References and evidence
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735–1749.
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. N Engl J Med. 2014;371:2155–2166.
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol. 2015;65(20):2211–2221.
The supplied file cites a heart-failure subgroup paper under a title that could not be verified as written during this review. It has therefore not been retained as a verified reference for a CHF-specific index.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.